Back to search

University of Thessaly (UTH)

Μελέτη γενετικών βιοδεικτών σε ασθενείς με πολλαπλή σκλήρυνση

Abstract

dc:description

Introduction: Multiple sclerosis (MS) is a chronic disease of the central nervous system (CNS). Myeloid lineage cells (microglia and macrophages) may participate in the pathogenic mechanisms leading to MS. CD33 rs3865444 is a promoter variant previously associated with Alzheimer’s disease, whose role in MS remains obscure. Adenosine receptor subtype A2a (ADORA2A) and cytochrome P450 1A2 (CYP1A2) are involved into pathophysiological pathways such as caffeine metabolism and oxidative stress, which are associated with neurodegeneration and neuroinflammation. The aim of the current study was to examine the possible association between the CD33 rs3865444, the ADORA2A rs5760423 and the CYP1A2 rs762551 genetic variants and MS.Methods: We genotyped 1396 patients with MS and 400 healthy controls for the presence of the CD33 rs3865444, the ADORA2A rs5760423 and the CYP1A2 rs762551 variants. The SNPStats software was used to calculate odds ratios (ORs) with the respective 95% confidence intervals (CIs), assuming five genetic models (co-dominant, dominant, recessive, over-dominant, and log-additive), with the G allele as the reference allele, for CD33 rs3865444 and ADORA2A rs5760423, whereas for CYP1A2 rs762551 the reference allele was A. The value of 0.05 was set as the threshold for statistical significance.Results: CD33 rs3865444 was associated with MS risk in the dominant (GG vs. GT + TT; OR (95% C.I.) = 0.79 (0.63–0.99), p = 0.041) and the over-dominant (GG + TT vs. GT; OR (95% C.I.) = 0.77 (0.61–0.97), p = 0.03) modes of inheritance. Given that the GG genotype was more frequent, and the GT genotype was less frequent in MS patients compared to controls the observed difference in MS risk may be stemming from either the GG (as a risk factor) or the GT (as a protective factor) genotype of CD33 rs3865444. Furthermore, the ADORA2A rs5760423 and the CYP1A2 rs762551 variants were not associated with MS risk.Conclusions: Our preliminary results suggest a possible contribution of CD33 rs3865444 to MS. Therefore, larger multiethnic studies should be conducted, investigating the role of CD33 rs3865444 in MS.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tsouris, Zisis
  • Τσούρης, Ζήσης

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/54371

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tsouris, Zisis; Τσούρης, Ζήσης. Μελέτη γενετικών βιοδεικτών σε ασθενείς με πολλαπλή σκλήρυνση. University of Thessaly (UTH), 2023. http://hdl.handle.net/10442/hedi/54371